Frequency of antiparvovírus B 19 antibodies in rheumatoid arthritis and systemic lupus erythematosus

@inproceedings{Silva2014FrequencyOA,
  title={Frequency of antiparvov{\'i}rus B 19 antibodies in rheumatoid arthritis and systemic lupus erythematosus},
  author={Clemar Pereira da Silva and Joz{\'e}lia Rego and Vitalina de Souza Barbosa and Vitor Alves Cruz and N{\'i}lzio Ant{\^o}nio da Silva},
  year={2014}
}
Objective: To determine the frequency of antiparvovírus B19 (B19) antibodies in patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), and the possible correlation of anti-B19 seropositivity with disease activity and quality of life. Patients and methods: Serum samples from 57 patients with RA, 45 with SLE and 65 healthy controls were used. We applied protocol with clinical data, and the Disease Activity Score 28 (DAS 28), Systemic Lupus Erythematosus Disease Activity… CONTINUE READING

Tables from this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 41 REFERENCES

Antihuman parvovirus B19 nonstructural protein antibodies in patients with rheumatoid arthritis

Tzang B-S, Tsai C-C, +3 authors Hsu T-C
  • Clin Chim Acta
  • 2009

Neurologic manifestations associated with parvovirus B19 infection.

  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2009